261 related articles for article (PubMed ID: 26925822)
21. Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients.
Pino Lopez J; Kromer C; Herr R; Schmieder A; Bayerl C; Schaarschmidt ML
Eur J Dermatol; 2021 Apr; 31(2):233-238. PubMed ID: 33871362
[TBL] [Abstract][Full Text] [Related]
22. [Safety of azathioprine therapy adjusted to thiopurine methyltransferase activity in the treatment of infantile atopic dermatitis. Report on 7 cases].
Martel RM; Melwani P; Islas D; Peñate Y; Borrego L
Actas Dermosifiliogr; 2010 Jun; 101(5):415-20. PubMed ID: 20525484
[TBL] [Abstract][Full Text] [Related]
23. Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy.
Gori N; Chiricozzi A; Malvaso D; D'Urso DF; Caldarola G; De Simone C; Peris K
Dermatology; 2021; 237(4):535-541. PubMed ID: 33477153
[TBL] [Abstract][Full Text] [Related]
24. Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
Roekevisch E; Leeflang MMG; Schram ME; Campbell LE; Irwin McLean WH; Kezic S; Bos JD; Spuls PI; Middelkamp-Hup MA
Br J Dermatol; 2017 Dec; 177(6):1745-1746. PubMed ID: 27864930
[No Abstract] [Full Text] [Related]
25. Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands.
Garritsen FM; van den Heuvel JM; Bruijnzeel-Koomen CAFM; Maitland-van der Zee AH; van den Broek MPH; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1336-1342. PubMed ID: 29485224
[TBL] [Abstract][Full Text] [Related]
26. Treatment patterns in UK adult patients with atopic dermatitis treated with systemic immunosuppressants: data from The Health Improvement Network (THIN).
Eckert L; Amand C; Gadkari A; Rout R; Hudson R; Ardern-Jones M
J Dermatolog Treat; 2020 Dec; 31(8):815-820. PubMed ID: 31305182
[No Abstract] [Full Text] [Related]
27. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
Davis DMR; Drucker AM; Alikhan A; Bercovitch L; Cohen DE; Darr JM; Eichenfield LF; Frazer-Green L; Paller AS; Schwarzenberger K; Silverberg JI; Singh AM; Wu PA; Sidbury R
J Am Acad Dermatol; 2024 Feb; 90(2):e43-e56. PubMed ID: 37943240
[TBL] [Abstract][Full Text] [Related]
28. The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis.
Tsianakas A; Luger TA
Expert Opin Biol Ther; 2015; 15(11):1657-60. PubMed ID: 26457448
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Gerbens LAA; Hamann SAS; Brouwer MWD; Roekevisch E; Leeflang MMG; Spuls PI
Br J Dermatol; 2018 Jun; 178(6):1288-1296. PubMed ID: 29237228
[TBL] [Abstract][Full Text] [Related]
30. Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative.
Rademaker M; Agnew K; Andrews M; Baker C; Foley P; Gebauer K; Gupta M; Rubel DM; Somerville C; Sullivan J; Wong LC
Australas J Dermatol; 2020 Feb; 61(1):9-22. PubMed ID: 31529493
[TBL] [Abstract][Full Text] [Related]
31. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
Dalaker M; Bonesrønning JH
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
[TBL] [Abstract][Full Text] [Related]
32. A Monocentric Retrospective Cohort of Patients with Severe Atopic Dermatitis Treated with Cyclosporine A in Daily Practice.
Daguzé J; Aubert H; Bernier C; Gaultier A; Nguyen JM; Stalder JF; Barbarot S
Acta Derm Venereol; 2017 Aug; 97(8):955-956. PubMed ID: 28448098
[No Abstract] [Full Text] [Related]
33. Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD).
de Bruin-Weller M; Pink AE; Ferrucci SM; Patrizi A; Svensson A; Schuttelaar MLA; Tauber M; Ardeleanu M; Jayawardena S; Daoud M
J Dermatolog Treat; 2022 Aug; 33(5):2565-2570. PubMed ID: 35255779
[TBL] [Abstract][Full Text] [Related]
34. Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
Davis DMR; Drucker AM; Alikhan A; Bercovitch L; Cohen DE; Darr JM; Eichenfield LF; Frazer-Green L; Paller AS; Schwarzenberger K; Silverberg JI; Singh AM; Wu PA; Sidbury R
J Am Acad Dermatol; 2024 Feb; 90(2):342-345. PubMed ID: 37943241
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis.
Hijnen DJ; ten Berge O; Timmer-de Mik L; Bruijnzeel-Koomen CA; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):85-9. PubMed ID: 17207173
[TBL] [Abstract][Full Text] [Related]
36. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
Sidbury R; Davis DM; Cohen DE; Cordoro KM; Berger TG; Bergman JN; Chamlin SL; Cooper KD; Feldman SR; Hanifin JM; Krol A; Margolis DJ; Paller AS; Schwarzenberger K; Silverman RA; Simpson EL; Tom WL; Williams HC; Elmets CA; Block J; Harrod CG; Begolka WS; Eichenfield LF;
J Am Acad Dermatol; 2014 Aug; 71(2):327-49. PubMed ID: 24813298
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center.
Dvorakova V; O'Regan GM; Irvine AD
Pediatr Dermatol; 2017 Sep; 34(5):528-534. PubMed ID: 28730617
[TBL] [Abstract][Full Text] [Related]
38. Retrospective review of relapse after systemic cyclosporine in children with atopic dermatitis.
Sibbald C; Pope E; Ho N; Weinstein M
Pediatr Dermatol; 2015; 32(1):36-40. PubMed ID: 25059452
[TBL] [Abstract][Full Text] [Related]
39. A Retrospective Study of Systemic Treatment of Severe Atopic Dermatitis With Azathioprine: Effectiveness and Tolerance in 11 Pediatric Patients.
Noguera-Morel L; Knöpfel N; Torrelo A; Hernández-Martín A
Actas Dermosifiliogr (Engl Ed); 2019 Apr; 110(3):227-231. PubMed ID: 30376955
[TBL] [Abstract][Full Text] [Related]
40. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
